Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX
Bedrosian Camille L received 22,807 Amylyx Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Aug 18, 2026 · Filed Aug 20, 2026
On Aug 18, 2026, Bedrosian Camille L (Chief Medical Officer) received 22,807 Amylyx Pharmaceuticals, Inc. shares as an award, leaving 288,092 shares. Filed Aug 20, 2026 (Form 4).
- Awarded
- 22,807 shares
- Holding after
- 288,092 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | Award | 22,807 | 288,092 | Direct |
Source
Related
- Amylyx Pharmaceuticals, Inc.
- Bedrosian Camille L
- Amylyx Pharmaceuticals, Inc. shareholders
- Form 4 · Bedrosian Camille L · Sep 14, 2026
- Form 4 · Milne George M Jr · Oct 7, 2026
- Form 4 · Frates James M · Sep 14, 2026
- Form 4 · Mazzariello Gina · Sep 14, 2026
- Form 4 · Cohen Joshua B · Sep 14, 2026
- Form 4 · Klee Justin B. · Sep 14, 2026